Dare Bioscience Inc (Nasdaq:DARE)
December 6th, 2018
Dare Bioscience Inc went up $0.13 Thursday, up 15.16%, closing at $0.98. Dare Bioscience Inc bounced 50.00% between low and high. In addition to finishing higher, trading volumes were solid at 17,922% of normal which can indicate investors see opportunities.
DARE outperformed the rest of the Healthcare sector which went down 0.31% today.
The market sectors were mixed Thursday with a majority of the sectors trending down. Real Estate saw the biggest increase of the day (2.66%), while Energy saw the biggest drop (1.77%). Healthcare has seen the biggest year-to-date gain at 13%. The biggest loss this year has been the Communication Services sector dropping 13%.
Communication Services saw the biggest turnaround from its 5-day performance of -0.23%, as it went up 1.04%. Energy and Materials both saw turn arounds from their five day positive performance, Energy with a drop of 1.77%.
- Real Estate went up with a 2.66% change.
- Communication Services went up with a 1.04% change.
- Consumer Discretionary went up with a 0.61% change.
- Information Technology went up with a 0.23% change.
- Utilities went down with a -0.10% change.
- Consumer Staples went down with a -0.10% change.
- Healthcare went down with a -0.31% change.
- Industrials went down with a -0.55% change.
- Materials went down with a -1.36% change.
- Financials went down with a -1.44% change.
- Energy went down with a -1.77% change.
Dare Bioscience Inc Info
As of July 19, 2017, Cerulean Pharma Inc. was acquired by Daré Bioscience, Inc., in a reverse merger transaction. Cerulean Pharma Inc. develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. It has a collaboration with Novartis Institutes for BioMedical Research, Inc. to develop nanoparticle-drug conjugates. The company was formerly known as Tempo Pharmaceuticals, Inc. and changed its name to Cerulean Pharma Inc. in October 2008. Cerulean Pharma Inc. was incorporated in 2005 and is headquartered in Waltham, Massachusetts.
All amounts in USD unless otherwise indicated
Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.